Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -5 | 58 | -14 | -32 | -1 |
| Other Working Capital | -3 | -2 | 76 | -152 | -107 |
| Other Operating Activity | -462 | -332 | -1,698 | -699 | -387 |
| Operating Cash Flow | $-470 | $-276 | $-1,636 | $-883 | $-496 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -30 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-30 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 26 | 39 | 39 | 39 | 38 |
| Debt Repayment | -26 | -79 | -39 | -39 | -38 |
| Other Financing Activity | 0 | 0 | 2,017 | 0 | 0 |
| Financing Cash Flow | $0 | $-40 | $2,017 | $0 | $0 |
| Beginning Cash Position | 773 | 1,049 | 708 | 1,592 | 2,087 |
| End Cash Position | 273 | 773 | 1,049 | 708 | 1,592 |
| Net Cash Flow | $-500 | $-276 | $341 | $-883 | $-496 |
| Free Cash Flow | |||||
| Operating Cash Flow | -470 | -276 | -1,636 | -883 | -496 |
| Free Cash Flow | -470 | -276 | -1,636 | -883 | -496 |